JCB, Volume 14, Number 2, 2008 Editorial Vol.14 No. 2 (2008) Editorial Yali Friedman   Article Vol.14 No. 2 (2008) Export compliance for life sciences John Avellanet Long before worrying about US Food and Drug Administration compliance, organisations that work with foreign employees, contractors, vendors or partners need to be conce Article Vol.14 No. 2 (2008) A new approach to improve technology commercialisation in university medical schools Courtney Price US university-based technology transfer has grown exponentially since the passage of the Bayh–Dole Act in 1980. As a result, invention disclosures and technology Article Vol.14 No. 2 (2008) Biotechnology business models work: Evidence from the pharmaceutical marketplace J Leslie Glick A study was undertaken that validates the business models of biotechnology companies that compete in the pharmaceutical marketplace. Strategic alliances, largely with e Article Vol.14 No. 2 (2008) Valuing biotechnology companies: Does classification by technology type help? Jacqueline Loh This paper explores whether conventional financial ratios can be used for portfolio construction in the biotechnology sector after the companies are classified into gro Article Vol.14 No. 2 (2008) Risk management for the biotechnology industry: A Canadian perspective Sandra Vanderbyl In order to break down industry barriers and decrease failure rates, biotechnology companies require a sophisticated risk management plan. Biotechnology is an industry Article Vol.14 No. 2 (2008) Singapore's biomedical sciences landscape Keat-Chuan Yeoh Singapore's vision is to be the Biopolis of Asia, a leading international biomedical sciences cluster advancing human health, through the pursuit of excellence in resea Article Vol.14 No. 2 (2008) Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint Yoshihiro Okada Corporate social responsibility (CSR) is discussed, targeting a broad range of industries. As yet, little work on CSR has focused on the specific situation of each indu Legal and Regulatory Updates Vol.14 No. 2 (2008) Legal and regulatory update Gerry Kamstra   Conference Report Vol.14 No. 2 (2008) Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference Harley King   Book Review Vol.14 No. 2 (2008) Book Review: Stem cell wars: Inside stories from the Frontlines Grant H Skrepnek Stem cell wars: Inside stories from the Frontlines Eve Herold. foreword by Dr George Q. Daley Palgrave Macmillan, New York; ISBN 978 1403974990; 2006; 238pp; Hardback